Sohanya Roshan Cheng serves as Executive at Karyopharm Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Sohanya Roshan Cheng has executed 17 insider transactions totaling $93.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 15, 2025 involved receiving (via award) 43,650 shares valued at $0.
Sohanya Roshan Cheng currently holds 79,506 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sohanya Roshan Cheng has been a net seller of KPTI stock. They have purchased $0 and sold $93.9K worth of shares.
Sohanya Roshan Cheng's most recent insider trade was on Oct 15, 2025, when they sold 43,650 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.43 |
| Discretionary |
| Sep 12, 2025 | KPTI | $0 | Award | 945 | $N/A | Discretionary |
| Sep 4, 2024 | KPTI | $3.9K | Sale | 5,356 | $0.72 | Discretionary |
| Mar 1, 2024 | KPTI | $6.1K | Sale | 5,109 | $1.20 | Discretionary |
| Feb 29, 2024 | KPTI | $25.6K | Sale | 21,840 | $1.17 | Discretionary |
| Feb 28, 2024 | KPTI | $0 | Award | 198,959 | $N/A | Discretionary |
| Jan 24, 2024 | KPTI | $0 | Award | 14,167 | $N/A | Discretionary |
| Sep 1, 2023 | KPTI | $9.9K | Sale | 7,415 | $1.33 | Discretionary |
| Jun 8, 2023 | KPTI | $4.3K | Sale | 1,839 | $2.35 | Planned |
| Mar 1, 2023 | KPTI | $34.1K | Sale | 11,239 | $3.03 | Discretionary |
| Feb 28, 2023 | KPTI | $0 | Award | 100,000 | $N/A | Discretionary |
| Aug 31, 2022 | KPTI | $0 | Award | 30,000 | $N/A | Discretionary |
| Jun 13, 2022 | KPTI | $353 | Sale | 66 | $5.35 | Discretionary |
| Jun 13, 2022 | KPTI | $7.7K | Sale | 1,485 | $5.20 | Discretionary |
| Feb 28, 2022 | KPTI | $0 | Award | 84,000 | $N/A | Discretionary |
| Jun 30, 2021 | KPTI | $0 | Award | 7,500 | $N/A | Discretionary |